Type 2 Diabetes Mellitus in Obese Clinical Trial
Official title:
Type 2 Diabetes Mellitus With Obesity and Dyslipidemia Treated by Chinese Herbal Medicine: a Retrospective Study
This study is a retrospective review of participants who visited Department of Endocrinology, Guang'anmen Hospital and accepted traditional Chinese medicine formula for at least sis months, from January 2015 to December 2020. All the participants should be diagnosed as type 2 diabetes mellitus, obesity and dyslipidemia. Therapeutic effect of traditional Chinese medicine will be evaluated based on the changes of blood glucose, body mass index, blood lipids, and blood pressure.
The diagnostic criteria for type 2 diabetes mellitus and obesity are based on the Guideline for the prevention and treatment of type 2 diabetes mellitus in China (2020 edition). The diagnostic criteria of dyslipidaemia are based on the Chinese Guidelines on Prevention and Treatment of Dyslipidaemia in Adults (2016, revision edition). ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05606471 -
Glucagon-like Peptide-1 Agonism With Very Low Calorie Diets
|
Phase 4 | |
Withdrawn |
NCT02977039 -
Effect of a Plant Rich Diet on in People With Type 2 Diabetes and Obesity
|
N/A | |
Recruiting |
NCT06223490 -
Effect of Cryolipolysis on Insulin Resistance
|
N/A | |
Completed |
NCT04363710 -
Prospective Interventional Study on Reversibility of Type 2 Diabetes Mellitus With Hypocaloric Diet
|
N/A | |
Recruiting |
NCT05277558 -
Brain Health in Youth With Normal Weight, Overweight and Obesity at Risk for Type 2 Diabetes (T2D)
|
||
Recruiting |
NCT04621929 -
Obesity and Uric Acid Stones Study
|
Phase 3 | |
Completed |
NCT04332354 -
Glycemic Profile by CGMS in Diabetic Patients After Bariatric Surgery
|
||
Completed |
NCT05890950 -
A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of K-757 and K-833 in Overweight/Obese Patients With Type 2 Diabetes
|
Phase 1 | |
Not yet recruiting |
NCT06442150 -
LCMD for Type 2 Diabetes Remission: Evaluation of Effectiveness and Exploration of Individual Differences
|
N/A | |
Withdrawn |
NCT04910997 -
Heart Rate Variability-Guided Exercise Training in Type 2 Diabetes
|
N/A | |
Completed |
NCT04931836 -
The Influence of Physical Activity on the Gut Microbiome of Pre-Diabetic Adults
|
N/A | |
Recruiting |
NCT06005012 -
Semaglutide Treatment in the Real-world for Fibrosis Due to NAFLD in Obesity and T2DM
|
Phase 2 | |
Completed |
NCT05409027 -
A Study to Assess 11 Beta-hydroxysteroid Dehydrogenase Type 1 Inhibition in Adipose Tissue by SPI-62
|
Phase 1 | |
Terminated |
NCT04741074 -
Effect of Subcutaneous Semaglutide on Kidney Transplant Candidacy
|
Phase 3 | |
Recruiting |
NCT05838287 -
Pioglitazone on Heart Failure in Type-2 Diabetes Mellitus Participants
|
Phase 4 | |
Active, not recruiting |
NCT04916314 -
REmote SUpport for Low-Carbohydrate Treatment of Type 2 Diabetes
|
N/A | |
Completed |
NCT04303819 -
The Effect of Exenatide on Fasting Bile Acids
|
||
Recruiting |
NCT05446415 -
L-Cell Activity in Small Intestine as Biliopancreatic Loop in Obese Patients With DM2 Submitted to RYGBP
|
N/A | |
Completed |
NCT05770076 -
Probiotic Lysate (Postbiotic and Metabiotic) Supplementation for Type 2 Diabetes Patients (DELI_Diab Study)
|
N/A | |
Completed |
NCT02937987 -
Dietary Intake, Eating Behavior, Physical Activity Level and Their Relationships With Glycemic and Weight Control in Hong Kong Chinese Type 2 Diabetic Patients
|